» Articles » PMID: 33896254

Necrotizing Soft Tissue Infections in Intensive Care

Overview
Publisher Sage Publications
Specialty Critical Care
Date 2021 Apr 26
PMID 33896254
Citations 3
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Necrotizing soft tissue infections (NSTIs) are typically characterized by extensive soft tissue destruction with systemic signs of toxicity, ranging from sepsis to septic shock. Our aim was to analyze the clinical characteristics, microbiological results, laboratory data, therapies, and outcome of patients with NSTIs admitted to an intensive care unit (ICU).

Methods: A monocentric observational study of patients admitted to the ICU of a university hospital between January 2009 and December 2017. The demographic characteristics, comorbidities, clinical features, microbiology and laboratory results, organ dysfunctions, therapies, and outcome were retrospectively analyzed.

Results: There were 59 patients and 70% males. The mean age (± SD) was 55 ± 18; type II (monomicrobial) NSTI was present in 36 patients (61%); the most common isolated pathogen was in 28 patients (48%). Septic shock was diagnosed in 41 patients (70%). The most common organ dysfunctions were circulatory and renal in 42 (71%) and 38 patients (64%). The mean value (± SD) of serum lactate at admission to the ICU was 4.22 ± 5.42 mmol/l, the median SOFA score and SAPS II were 7 (IQR 4 - 10) and 46 (IQR 30.5 - 53). ICU mortality rate was 25%. Both SOFA score and serum lactate demonstrated a good prognostic value regarding ICU outcome (OR 1.29, 95%CI 1.07-1.57, < 0.007 and OR 1.53, 95%CI 1.19-1.98, < 0.001). A cut-off value for serum lactate of 6.55 mmol/L positively predicted mortality with 67% sensitivity and 97% specificity.

Conclusion: NSTIs carry a high risk of septic shock and multiple organ dysfunction syndrome and thus are still associated with high mortality. In our study, the value of serum lactate at admission to the ICU correlated well with mortality. This easy-to-measure parameter could play a role in the decision-making process regarding prognosis and continuation of care.

Citing Articles

Risk Factors for Predicting Mortality and Amputation of Patients with Necrotizing Soft-Tissue Infections: Retrospective Analysis of 111 Cases from a Single Medical Center.

Cen H, Jin R, Yin J, Wang X Emerg Med Int. 2023; 2023:6316896.

PMID: 38029225 PMC: 10657247. DOI: 10.1155/2023/6316896.


Necrotizing soft tissue infections in critically ill neutropenic patients: a French multicentre retrospective cohort study.

Arrestier R, Chaba A, Mabrouki A, Saccheri C, Canet E, De Chambrun M Ann Intensive Care. 2023; 13(1):34.

PMID: 37115415 PMC: 10147851. DOI: 10.1186/s13613-023-01125-w.


An Overview of Clinical Manifestations of Dermatological Disorders in Intensive Care Units: What Should Intensivists Be Aware of?.

Al Bshabshe A, Mousa W, Nor El-Dein N Diagnostics (Basel). 2023; 13(7).

PMID: 37046508 PMC: 10093365. DOI: 10.3390/diagnostics13071290.

References
1.
Kulasegaran S, Cribb B, Vandal A, McBride S, Holland D, MacCormick A . Necrotizing fasciitis: 11-year retrospective case review in South Auckland. ANZ J Surg. 2015; 86(10):826-830. DOI: 10.1111/ans.13232. View

2.
Brunkhorst F, Weigand M, Pletz M, Gastmeier P, Lemmen S, Meier-Hellmann A . [S3 Guideline Sepsis-prevention, diagnosis, therapy, and aftercare : Long version]. Med Klin Intensivmed Notfmed. 2020; 115(Suppl 2):37-109. DOI: 10.1007/s00063-020-00685-0. View

3.
van de Sande M, van Slobbe-Bijlsma E . Necrotizing fasciitis in a rheumatoid arthritis patient treated with tocilizumab. Rheumatology (Oxford). 2011; 51(3):577-8. DOI: 10.1093/rheumatology/ker336. View

4.
van Stigt S, de Vries J, Bijker J, Mollen R, Hekma E, Lemson S . Review of 58 patients with necrotizing fasciitis in the Netherlands. World J Emerg Surg. 2016; 11:21. PMC: 4884415. DOI: 10.1186/s13017-016-0080-7. View

5.
Chang C, Fann W, Wu S, Lin C, Hsiao C . Lactate on emergency department arrival as a predictor of in-hospital mortality in necrotizing fasciitis: a retrospective study. J Orthop Surg Res. 2019; 14(1):73. PMC: 6402084. DOI: 10.1186/s13018-019-1108-y. View